We are live on ! Find out more
ICU icon

SeaStar Medical

28 hedge funds and large institutions have $2.84M invested in SeaStar Medical in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 1

545% more capital invested

Capital invested by funds: $440K → $2.84M (+$2.4M)

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

33% more funds holding

Funds holding: 2128 (+7)

0.01% more ownership

Funds ownership: 0.01%0.02% (+0.01%)

Holders
28
Holders Change
+7
Holders Change %
+33.33%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
10
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change

ICU Hedge Fund Activity: Q1 2024 in Review

28 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q1 2024, worth a combined $2.84M — up 545% from $440K a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ICU positions and 5 closed out — a net gain of 7 holders — while 10 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.03M. The largest seller was Darden Wealth Group, exiting entirely with an estimated $42.2K sold.

  • 28 institutional investors held SeaStar Medical (ICU) as of Q1 2024, up from 21 in Q4 2023.
  • Funds reported $2.84M of SeaStar Medical stock for Q1 2024, up 545% quarter-over-quarter.
  • 12 funds opened new SeaStar Medical positions in Q1 2024 and 5 closed out, a net change of +7 holders.
  • The largest SeaStar Medical buyer in Q1 2024 was Morgan Stanley, an estimated $1.03M added.
  • The largest SeaStar Medical seller in Q1 2024 was Darden Wealth Group, an estimated $42.2K sold.

Based on aggregated 13F filings for Q1 2024.